Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

23341 Press Releases
DateTitleCompany
21 Apr 15 MaxCyte and Johns Hopkins University Announce Strategic Immuno-Oncology Collaboration to Advance CAR T-cell Therapies MaxCyte, Inc.,
Published by
Business Wire
21 Apr 15 Globus Medical Schedules First Quarter 2015 Earnings Release and Conference Call Globus Medical, Inc.,
Published by
Business Wire
21 Apr 15 Epizyme Presents Preclinical Research Providing Deeper Understanding of Multiple Cancer Targets Epizyme, Inc.,
Published by
Business Wire
20 Apr 15 Fred’s Completes Acquisition of Reeves-Sain Drug Store and EntrustRx Specialty Pharmacy Fred’s, Inc.,
Published by
Business Wire
20 Apr 15 Agilent Technologies Inc. Recommends Stockholders Reject TRC Capital’s “Mini-Tender” Offer Agilent Technologies, Inc.,
Published by
Business Wire
20 Apr 15 PerkinElmer To Present at Baird 2015 Growth Stock Conference PerkinElmer, Inc.,
Published by
Business Wire
20 Apr 15 Aduro Biotech Announces Close of Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement Aduro Biotech, Inc.,
Published by
Business Wire
20 Apr 15 Infinity Reports Preclinical Data for Duvelisib in Combination with Venetoclax at the 2015 American Association for Cancer Research Annual Meeting Infinity Pharmaceuticals, Inc.,
Published by
Business Wire
20 Apr 15 OncoCyte Announces Initial Data From Ongoing Clinical Study of Collagen Type X as a Marker and Potential Diagnostic for Breast Cancer and Other Types of Human Cancers BioTime, Inc.,
Published by
Business Wire
20 Apr 15 Acetylon Announces Preclinical Anti-cancer Activity of Selective HDAC1/2 Inhibitors in Neuroblastoma and Acute Myeloid Leukemia Acetylon Pharmaceuticals, Inc.,
Published by
Business Wire
20 Apr 15 Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery Icon Bioscience Inc.,
Published by
Business Wire
20 Apr 15 Lab7 Systems Releases Clinical Annotation Manager for Lab7 ESP and Two Acceleration Programs Lab7 Systems, Inc.,
Published by
Business Wire
20 Apr 15 FDA Accepts Supplemental BLA and Grants Priority Review for ADCETRIS® (Brentuximab Vedotin) in the AETHERA Setting for the Post-Transplant Consolidation Treatment of Hodgkin Lymphoma Patients at High Risk of Relapse Seattle Genetics, Inc.,
Published by
Business Wire
20 Apr 15 Agenus to Report First Quarter 2015 Financial Results on April 23 2015; Conference Call to Follow Agenus Inc.,
Published by
Business Wire
20 Apr 15 Pernix Therapeutics Inc. Obtains Six Months U.S. Pediatric Exclusivity for Treximet Pernix Therapeutics Holdings, Inc.,
Published by
Business Wire
20 Apr 15 Transgenomic Launches New Multiplexed ICE-COLD PCR™ Service in Biomarker Identification Business Transgenomic, Inc.,
Published by
Business Wire
20 Apr 15 Global Strategic Partners Merck KGaA Darmstadt Germany and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
20 Apr 15 Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
20 Apr 15 Epizyme to Present Updated Data from Ongoing Phase 1 Dose Escalation Trial of EZH2 Inhibitor EPZ-6438 at International Conference on Malignant Lymphoma Epizyme, Inc.,
Published by
Business Wire
20 Apr 15 RainDance Launches ThunderBolts Next-Gen Sequencing Panel to Research Genetic Mutations for Myeloid Malignancies RainDance Technologies, Inc.,
Published by
Business Wire
20 Apr 15 Exosome Diagnostics Presents Data Demonstrating Ability to Detect EML4-ALK Fusion Transcripts on Exosomal RNA in Patients with Non-Small Cell Lung Cancer Exosome Diagnostics, Inc.,
Published by
Business Wire
20 Apr 15 Opexa Therapeutics Invited to Present Biomarker Data from NMO Patients at The American Academy of Neurology (AAN) 2015 Annual Meeting Opexa Therapeutics, Inc.,
Published by
Business Wire
20 Apr 15 Foundation Medicine and Collaborators to Present New Data in 12 Oral and Poster Presentations at the AACR Annual Meeting Foundation Medicine, Inc.,
Published by
Business Wire
20 Apr 15 Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device Cardiovascular Systems, Inc.,
Published by
Business Wire
20 Apr 15 Positive Clinical Results of OncoCyte’s PanC-Dx™ Diagnostic Test Demonstrate High Level of Sensitivity and Specificity in Non-Invasive Detection of Bladder Cancer BioTime, Inc.,
Published by
Business Wire
20 Apr 15 Pfizer and Provectus Biopharmaceuticals Receive Patent Allowance for Use of PV-10 in Combination with Systemic Immunotherapy Agents in Treatment of Cancer Provectus Biopharmaceuticals, Inc.,
Published by
Business Wire
20 Apr 15 Transposagen announces partnering model for its exclusive patents covering rat models of oncology autoimmune and inflammatory diseases and issuance of OncoRat(TM) registered trademark Transposagen Biopharmaceuticals, Inc.,
Published by
GlobeNewswire
20 Apr 15 New Report - Ziarco Pharma Ltd - Product Pipeline Review - 2014 Radiant Insights, Inc
20 Apr 15 Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014 Radiant Insights, Inc
19 Apr 15 Peloton Therapeutics Inc. Presents Promising Data on First Inhibitor of HIF-2a for Renal Cell Carcinoma at 2015 AACR Annual Meeting Peloton Therapeutics, Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.